Clinical Trials Logo

Hypercapnia clinical trials

View clinical trials related to Hypercapnia.

Filter by:

NCT ID: NCT02643030 Completed - Cerebral Ischemia Clinical Trials

Hypercapnia During Shoulder Arthroscopy

Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of hypercapnia on hemodynamics and cerebral oxygenation during shoulder arthroscopy.

NCT ID: NCT02564406 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Extracorporeal CO2 Removal in Hypercapnic Patients

Start date: January 2013
Phase: N/A
Study type: Interventional

Noninvasive ventilation represents the standard of care for patients with exacerbation of chronic obstructive pulmonary disease. However, NIV fails in almost 30% of the most severe forms of acute hypercapnic respiratory failure and patients must undergo endotracheal intubation and invasive ventilation to restore adequate gas exchange. Under these circumstances, patients may express a clear intention not to be intubated.The aim of this study is to retrospectively assess efficacy and safety of noninvasive ventilation- plus-extracorporeal Co2 removal in patients who fail NIV and refuse endotracheal intubation.

NCT ID: NCT02538263 Completed - Clinical trials for Acute Hypercapnic Respiratory Failure

Volume-targeted Versus Pressure-limited Noninvasive Ventilation in Patients With Acute Hypercapnic Respiratory Failure

Start date: January 2013
Phase: N/A
Study type: Interventional

Volume-targeted noninvasive ventilation (VT-NIV), a hybrid mode that targets a preseted tidal volume (VT) by automated adjustment of pressure support, could guarantee the delivered VT over pressure-limited noninvasive ventilation (PL-NIV) with fixed level pressure support. Whether VT-NIV is more effective in improving gas exchange in patients with acute hypercapnic respiratory failure (AHRF) as compared with PL-NIV remains unclear. Our aim was to verify whether in comparison with PL-NIV, use of VT-NIV was more effective in correcting hypercapnia, hence reducing the need for intubation and improving survival in patients with AHRF.

NCT ID: NCT02521272 Completed - Clinical trials for Accident Caused by Snow Avalanche

Hypercapnia and Gas Exchange Under the Avalanche Snow Model (HyperAvaSM)

HyperAvaSM
Start date: March 2012
Phase: N/A
Study type: Interventional

The aim of the study is to investigate respiratory parameters of a person in the simulated avalanche snow and consequent use of the measured data for development of a mathematical-physical model of breathing during increasing hypercapnia in the avalanche.

NCT ID: NCT02519517 Completed - Anesthesia Clinical Trials

Permissive Hypercapnia During One Lung Ventilation: Impact on Right Ventricular Systolic and Diastolic Functions During Lung Resection

Start date: November 2011
Phase: N/A
Study type: Interventional

Investigators studied 15 patients scheduled for pulmonary resection through thoracotomy. Initial tidal volume (VT) 10ml kg-1 was reduced to 8ml kg-1 after one lung ventilation (OLV) and the rate adjusted to maintain partial pressure of arterial carbon dioxide (PaCO2) 30-35 mm Hg. Data were obtained at: T1, 15 min post establishing OLV with normocapnia, T2, 15 min post establishing OLV with hypercapnia (PaCO2 7.98kPa (60mmHg) and 9.31kPa (70mmHg) and pH >7.1), and T3, 15 min after resuming OLV with normocapnia. One-way repeated measures analysis of variance (ANOVA), with post hoc Dunnet´s test were used for analysis. A P value < 0.05 is considered statistically significant.

NCT ID: NCT02504814 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Physiological and Clinical Changes in NHF Therapy

ATMOFLOW
Start date: June 2011
Phase: N/A
Study type: Interventional

The study explores the changes in pressure, volume and in hypercapnia in patients with COPD and ILD. The investigators will use different application forms.

NCT ID: NCT02429154 Completed - Hypercapnia Clinical Trials

Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO)

VARO
Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to show that a permissive hypercapnia during mechanical ventilation in children under general anaesthesia will improve cerebral perfusion.

NCT ID: NCT02363920 Completed - COPD Clinical Trials

Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics

Start date: March 2015
Phase: Phase 4
Study type: Interventional

Nasal High Oxygen Flow (HOF) has been demonstrated to reduce the re-intubation rate in hypoxic patients and ameliorate breathing pattern in hypercapnic patients. The aim of this study is to better understand the physiological mechanism underlying these results, assessing the respiratory mechanics in stable hypercapnic COPD patients.

NCT ID: NCT02264626 Recruiting - Clinical trials for Acute Hypercapnic Respiratory Failure

Sedation During Noninvasive Ventilation (NIV)

REMI
Start date: October 2014
Phase: N/A
Study type: Interventional

In patients undergoing NIV for acute respiratory, lack of tolerance is one of the main reason of failure. This may result in a poor synchrony between the patient and the machine, leading to gross mismatching and potentially to an increased work of breathing. The investigators aim to investigate whether in these patients poorly responding to NIV the use of a sedation protocol using remifentanil will lead to an improve patient-ventilator interaction and better compliance to NIV.

NCT ID: NCT02260583 Recruiting - Clinical trials for Chronic Respiratory Failure

Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients

Start date: October 2014
Phase: N/A
Study type: Interventional

Chronic hypercapnic respiratory failure is common in stable COPD patients in a terminal phase of their disease In an attempt to correct or slow down the rate of rise of PaCO2, long-term noninvasive mechanical ventilation (NIV) has been proposed. Only very few studies demonstrated the clinical efficacy of NIV. Indeed this technique is not always well tolerated and therefore it may be effective only in a subset of patients The aim of this study is to assess the feasibility and safety of "one shot" extrcorporeal CO2 removal device, in reducing the PaCO2 level